Related Experiment Videos
Midtrimester pregnancy termination with prostaglandin E2 vaginal suppositories
The Journal of Reproductive Medicine
|May 1, 1976
Summary
This study on prostaglandin E2 suppositories for elective pregnancy termination found a 93% abortion rate. While side effects were common, they were well-tolerated, with no long-term complications observed.
Area of Science:
- Obstetrics and Gynecology
- Reproductive Medicine
- Pharmacology
Background:
- Midtrimester pregnancy termination requires effective and safe methods.
- Prostaglandin E2 is a recognized agent for inducing labor and abortion.
Purpose of the Study:
- To evaluate the efficacy and safety of 20 mg prostaglandin E2 vaginal suppositories for elective midtrimester pregnancy termination.
Main Methods:
- One hundred midtrimester pregnancies underwent elective termination using 20 mg prostaglandin E2 vaginal suppositories.
- Data collected included abortion rates, time to abortion, dosage, and side effects.
Main Results:
- An overall abortion rate of 93% was achieved.
- Complete abortions occurred in 66% of cases, incomplete in 27%, and failures in 7%.
- Mean induction-abortion time was 17 hours and 26 minutes, with an average total dosage of 82 mg. Side effects were frequent but well-tolerated; no mortalities occurred.
Conclusions:
- Prostaglandin E2 vaginal suppositories are an effective method for midtrimester pregnancy termination.
- The procedure demonstrated a favorable safety profile with manageable side effects and no long-term sequelae.